Literature DB >> 17925545

Combining epigenetic and cytotoxic therapy in the treatment of solid tumors.

Elizabeth R Plimack, David J Stewart, Jean-Pierre J Issa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17925545     DOI： 10.1200/JCO.2007.12.6029

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

Review 1.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

2.  The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide.

Authors:  Erika L Moen; Amy L Stark; Wei Zhang; M Eileen Dolan; Lucy A Godley
Journal:  Mol Cancer Ther       Date:  2014-02-25       Impact factor: 6.261

3.  A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.

Authors:  Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; Lang Li; Carol Kulesavage; Anthony J Snyder; Kenneth P Nephew; Daniela E Matei
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

4.  Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells.

Authors:  Huey-Jen L Lin; Tao Zuo; Ching-Hung Lin; Chieh Ti Kuo; Sandya Liyanarachchi; Shuying Sun; Rulong Shen; Daniel E Deatherage; Dustin Potter; Lisa Asamoto; Shili Lin; Pearlly S Yan; Ann-Lii Cheng; Michael C Ostrowski; Tim H-M Huang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Integrating Epigenomics into Pharmacogenomic Studies.

Authors:  Wei Zhang; R Stephanie Huang; M Eileen Dolan
Journal:  Pharmgenomics Pers Med       Date:  2008-11

6.  Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).

Authors:  Chang Xia; Roberto Leon-Ferre; Douglas Laux; Jeremy Deutsch; Brian J Smith; Melanie Frees; Mohammed Milhem
Journal:  Cancer Chemother Pharmacol       Date:  2014-07-26       Impact factor: 3.333

7.  Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells.

Authors:  Joong-Gook Kim; Jin-Han Bae; Jin-Ah Kim; Kyu Heo; Kwangmo Yang; Joo Mi Yi
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

8.  Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study.

Authors:  Yousef Zakharia; Varun Monga; Umang Swami; Aaron D Bossler; Michele Freesmeier; Melanie Frees; Mirza Khan; Noah Frydenlund; Rithu Srikantha; Marion Vanneste; Michael Henry; Mohammed Milhem
Journal:  Oncotarget       Date:  2017-09-26

9.  Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.

Authors:  F Meng; G Sun; M Zhong; Y Yu; M A Brewer
Journal:  Br J Cancer       Date:  2013-01-31       Impact factor: 7.640

10.  Treatment with at homeopathic complex medication modulates mononuclear bone marrow cell differentiation.

Authors:  Beatriz Cesar; Ana Paula R Abud; Carolina C de Oliveira; Francolino Cardoso; Raffaello Popa Di Bernardi; Fernando S F Guimarães; Juarez Gabardo; Dorly de Freitas Buchi
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.